Analyst firms · Stifel · FULC
Stifel FULC price target and rating history
Fulcrum Therapeutics Inc. (FULC) · Health Care
Stifel rates Fulcrum Therapeutics Inc. (FULC) Hold with a $3 price target, as of its latest action on Jun 2, 2026. It has published 4 rating actions on FULC since March 2023, including 1 upgrade and 3 downgrades. Across 5 firms with a FULC price target in the last 12 months, the median target is $3. Stifel's target matches it.
- Current rating
- Hold
- Price target
- $3
- Median target, all firms
- $3
- Actions on FULC
- 4
Stifel price target on FULC
Every Stifel rating on FULC
- Jun 2, 2026
- Sep 12, 2024DowngradeStifel downgrades to Hold from Buy
- Aug 22, 2023
- Mar 9, 2023
How other firms rate FULC
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Piper Sandler | Neutral | $3 | Jun 2, 2026 |
| H.C. Wainwright | Neutral | $3 | Jun 2, 2026 |
| Leerink Partners | Market Perform | $4 | Jun 2, 2026 |
| Truist Securities | Hold | $4 | Jun 2, 2026 |
| Stifel | Hold | $3 | Jun 2, 2026 |
Questions about Stifel and FULC
- What is Stifel's price target for FULC?
- Stifel's latest stated price target for Fulcrum Therapeutics Inc. (FULC) is $3, from its action on Jun 2, 2026.
- What is Stifel's rating on FULC?
- Stifel rates FULC Hold, a neutral rating, as of Jun 2, 2026.
- When did Stifel last change its view on FULC?
- On Jun 2, 2026, Stifel downgrades to Hold from Buy, price target $3.
- How does Stifel's FULC target compare with other analysts?
- Across 5 firms with a FULC price target in the last 12 months, the median target is $3. Stifel's target matches it.
More FULC rating histories
All Stifel ratingsFULC news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.